Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1947 1
1949 1
1957 4
1958 2
1959 3
1960 2
1961 1
1962 1
1963 3
1964 4
1965 1
1967 4
1970 1
1971 2
1972 1
1973 7
1974 3
1975 2
1976 3
1977 4
1978 8
1979 17
1980 17
1981 16
1982 34
1983 22
1984 30
1985 18
1986 17
1987 26
1988 41
1989 34
1990 36
1991 45
1992 55
1993 52
1994 68
1995 78
1996 72
1997 86
1998 92
1999 110
2000 123
2001 154
2002 181
2003 231
2004 281
2005 341
2006 352
2007 426
2008 462
2009 501
2010 645
2011 716
2012 857
2013 848
2014 942
2015 968
2016 1057
2017 1118
2018 1158
2019 1293
2020 1573
2021 1767
2022 1166
Text availability
Article attribute
Article type
Publication date

Search Results

16,324 results
Results by year
Filters applied: . Clear all
Page 1
CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.
Ma X, Lu C, Chen Y, Li S, Ma N, Tao X, Li Y, Wang J, Zhou M, Yan YB, Li P, Heydari K, Deng H, Zhang M, Yi C, Ge L. Ma X, et al. Among authors: lu c. Cell. 2022 Apr 14;185(8):1325-1345.e22. doi: 10.1016/j.cell.2022.03.005. Epub 2022 Apr 1. Cell. 2022. PMID: 35366418
A genome-scale screen for synthetic drivers of T cell proliferation.
Legut M, Gajic Z, Guarino M, Daniloski Z, Rahman JA, Xue X, Lu C, Lu L, Mimitou EP, Hao S, Davoli T, Diefenbach C, Smibert P, Sanjana NE. Legut M, et al. Among authors: lu c. Nature. 2022 Mar;603(7902):728-735. doi: 10.1038/s41586-022-04494-7. Epub 2022 Mar 16. Nature. 2022. PMID: 35296855
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
Moreira ED Jr, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, Perez JL, Zerbini C, Dever ME, Jennings TW, Brandon DM, Cannon KD, Koren MJ, Denham DS, Berhe M, Fitz-Patrick D, Hammitt LL, Klein NP, Nell H, Keep G, Wang X, Koury K, Swanson KA, Cooper D, Lu C, Türeci Ö, Lagkadinou E, Tresnan DB, Dormitzer PR, Şahin U, Gruber WC, Jansen KU; C4591031 Clinical Trial Group. Moreira ED Jr, et al. Among authors: lu c. N Engl J Med. 2022 May 19;386(20):1910-1921. doi: 10.1056/NEJMoa2200674. Epub 2022 Mar 23. N Engl J Med. 2022. PMID: 35320659 Free PMC article. Clinical Trial.
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
Biermann J, Melms JC, Amin AD, Wang Y, Caprio LA, Karz A, Tagore S, Barrera I, Ibarra-Arellano MA, Andreatta M, Fullerton BT, Gretarsson KH, Sahu V, Mangipudy VS, Nguyen TTT, Nair A, Rogava M, Ho P, Koch PD, Banu M, Humala N, Mahajan A, Walsh ZH, Shah SB, Vaccaro DH, Caldwell B, Mu M, Wünnemann F, Chazotte M, Berhe S, Luoma AM, Driver J, Ingham M, Khan SA, Rapisuwon S, Slingluff CL Jr, Eigentler T, Röcken M, Carvajal R, Atkins MB, Davies MA, Agustinus A, Bakhoum SF, Azizi E, Siegelin M, Lu C, Carmona SJ, Hibshoosh H, Ribas A, Canoll P, Bruce JN, Bi WL, Agrawal P, Schapiro D, Hernando E, Macosko EZ, Chen F, Schwartz GK, Izar B. Biermann J, et al. Among authors: lu c. Cell. 2022 Jul 7;185(14):2591-2608.e30. doi: 10.1016/j.cell.2022.06.007. Cell. 2022. PMID: 35803246
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.
Thomas SJ, Perez JL, Lockhart SP, Hariharan S, Kitchin N, Bailey R, Liau K, Lagkadinou E, Türeci Ö, Şahin U, Xu X, Koury K, Dychter SS, Lu C, Gentile TC, Gruber WC. Thomas SJ, et al. Among authors: lu c. Vaccine. 2022 Mar 1;40(10):1483-1492. doi: 10.1016/j.vaccine.2021.12.046. Epub 2021 Dec 24. Vaccine. 2022. PMID: 35131133 Free PMC article. Clinical Trial.
Spotlighting main group elements in polynuclear complexes.
Gabbaï FP, Jones C, Lu CC. Gabbaï FP, et al. Among authors: lu cc. Chem Sci. 2021 Feb 17;12(6):1961-1963. doi: 10.1039/d1sc90011k. eCollection 2021 Feb 14. Chem Sci. 2021. PMID: 35340399 Free PMC article.
16,324 results
You have reached the last available page of results. Please see the User Guide for more information.